DaVita (0I7E) Share Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0I7E Analyst Ratings

Moderate Buy

3 Buy

2 Hold

1 Sell

Based on 6 analysts giving stock ratings to

DaVita

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0I7E Stock 12 Month Forecast

Average Price Target

$238.80

▲(0.99% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for DaVita in the last 3 months. The average price target is $238.80 with a high forecast of $270.00 and a low forecast of $215.00. The average price target represents a 0.99% change from the last price of $236.46.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"108":"$108","271":"$271","148.75":"$148.8","189.5":"$189.5","230.25":"$230.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":270,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$270.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":238.8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$238.80</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":215,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$215.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[108,148.75,189.5,230.25,271],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,239.75,242.07692307692307,244.40384615384616,246.73076923076923,249.05769230769232,251.3846153846154,253.71153846153845,256.03846153846155,258.36538461538464,260.6923076923077,263.0192307692308,265.34615384615387,267.6730769230769,{"y":270,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,239.75,239.6769230769231,239.60384615384615,239.53076923076924,239.4576923076923,239.3846153846154,239.31153846153848,239.23846153846154,239.16538461538462,239.0923076923077,239.01923076923077,238.94615384615386,238.87307692307692,{"y":238.8,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,239.75,237.84615384615384,235.94230769230768,234.03846153846155,232.1346153846154,230.23076923076923,228.32692307692307,226.42307692307693,224.51923076923077,222.6153846153846,220.71153846153845,218.80769230769232,216.90384615384616,{"y":215,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":137.32,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":137.615,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":133.14,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":118.769,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":120.23,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":113.52,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":109.2,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":154.42,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":152.23,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":153.15,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":191.56,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":229.68,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":239.75,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$270.00

Average Price Target$238.80

Lowest Price Target$215.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David S Macdonald

Truist Financial

$215

Hold

-9.08%

Downside

Reiterated

08/11/26

Truist Financial Remains a Hold on DaVita (DVA)

Andrew Mok CFA

Barclays

$224

Hold

-5.27%

Downside

Reiterated

08/11/26

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (NYSE: HIMS), Lifestance Health Group (NASDAQ: LFST) and DaVita (NYSE: DVA)

Ryan Langston

TD Cowen

$201→$220

Buy

-6.96%

Downside

Upgraded

08/07/26

DaVita upgraded to Buy from Hold at TD CowenDaVita upgraded to Buy from Hold at TD Cowen

Pito Chickering

Deutsche Bank

$220→$265

Buy

12.07%

Upside

Assigned

08/05/26

DaVita price target raised to $265 from $220 at Deutsche BankDaVita price target raised to $265 from $220 at Deutsche Bank

Kevin Fischbeck

Bank of America Securities

―

Sell

―

Reiterated

08/05/26

Analysts Offer Insights on Healthcare Companies: TG Therapeutics (NASDAQ: TGTX), Syndax Pharmaceuticals (NASDAQ: SNDX) and DaVita (NYSE: DVA)

A.J. Rice

UBS

$235→$270

Buy

14.18%

Upside

Assigned

07/10/26

DaVita price target raised to $270 from $235 at UBSDaVita price target raised to $270 from $235 at UBS

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David S Macdonald

Truist Financial

$215

Hold

-9.08%

Downside

Reiterated

08/11/26

Truist Financial Remains a Hold on DaVita (DVA)

Andrew Mok CFA

Barclays

$224

Hold

-5.27%

Downside

Reiterated

08/11/26

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (NYSE: HIMS), Lifestance Health Group (NASDAQ: LFST) and DaVita (NYSE: DVA)

Ryan Langston

TD Cowen

$201→$220

Buy

-6.96%

Downside

Upgraded

08/07/26

DaVita upgraded to Buy from Hold at TD CowenDaVita upgraded to Buy from Hold at TD Cowen

Pito Chickering

Deutsche Bank

$220→$265

Buy

12.07%

Upside

Assigned

08/05/26

DaVita price target raised to $265 from $220 at Deutsche BankDaVita price target raised to $265 from $220 at Deutsche Bank

Kevin Fischbeck

Bank of America Securities

―

Sell

―

Reiterated

08/05/26

Analysts Offer Insights on Healthcare Companies: TG Therapeutics (NASDAQ: TGTX), Syndax Pharmaceuticals (NASDAQ: SNDX) and DaVita (NYSE: DVA)

A.J. Rice

UBS

$235→$270

Buy

14.18%

Upside

Assigned

07/10/26

DaVita price target raised to $270 from $235 at UBSDaVita price target raised to $270 from $235 at UBS

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ODTXOdyssey Therapeutics, Inc.

BTSGBrightSpring Health Services, Inc.

GPCRStructure Therapeutics, Inc. Sponsored ADR

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering DaVita

3 Months

Pito ChickeringDeutsche Bank

Success Rate

4/12 ratings generated profit

Average Return

-2.19%

Copying Pito Chickering's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -2.19% per trade.

1 Year

Pito ChickeringDeutsche Bank

Success Rate

2/12 ratings generated profit

Average Return

-11.18%

Copying Pito Chickering's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -11.18% per trade.

2 Years

Kevin FischbeckBank of America Securities

Success Rate

3/13 ratings generated profit

Average Return

-28.48%

Copying Kevin Fischbeck's trades and holding each position for 2 Years would result in 23.08% of your transactions generating a profit, with an average return of -28.48% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0I7E Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0I7E has received 3 Buy Ratings, 7 Hold Ratings, and 1 Sell Ratings. 0I7E average Analyst price target in the past 3 months is 238.80.

Each month's total comprises the sum of three months' worth of ratings.

0I7E Financial Forecast

0I7E Earnings Forecast

Next quarter’s earnings estimate for 0I7E is $3.58 with a range of $3.41 to $4.03. The previous quarter’s EPS was $4.02. 0I7E beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0I7E has Performed in-line its overall industry.

0I7E Sales Forecast

Next quarter’s sales forecast for 0I7E is $3.51B with a range of $3.46B to $3.54B. The previous quarter’s sales results were $3.55B. 0I7E beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0I7E has Performed in-line its overall industry.

0I7E Stock Forecast FAQ

What is GB:0I7E’s average 12-month price target, according to analysts?

Based on analyst ratings, DaVita Inc.’s 12-month average price target is 238.80.

What is GB:0I7E’s upside potential, based on the analysts’ average price target?

DaVita Inc. has 0.99% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is DaVita Inc. a Buy, Sell or Hold?

DaVita Inc. has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 2 hold ratings and 1 sell ratings.

What is DaVita Inc.’s share price target?

The average share price target for DaVita Inc. is 238.80. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $270.00 ,and the lowest forecast is $215.00. The average share price target represents 0.99% Increase from the current price of $236.46.

What do analysts say about DaVita Inc.?

DaVita Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of DaVita Inc.?

To buy shares of GB:0I7E, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

DaVita (0I7E) Share Forecast & Price Target

0I7E Analyst Ratings

0I7E Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering DaVita

0I7E Analyst Recommendation Trends

0I7E Financial Forecast

0I7E Earnings Forecast

0I7E Sales Forecast

0I7E Stock Forecast FAQ

Detailed List of Analyst Forecasts